Israeli generic pharmaceutical giant Teva has announced that it has entered into agreement to acquire American pharmaceutical and drug delivery company MicroDose Therapeutx. According to the agreement, Teva will pay $40 million at closing and up to an additional $125 million in milestone payments.
Related posts
Israeli Pineapple-Based Burn Therapy Treating Injured US Troops
October 02, 2023
AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023
Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023
Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Facebook comments